Subventricular zone-derived neural stem cell grafts protect against hippocampal degeneration and restore cognitive function in the mouse following intrahippocampal kainic acid administration

Stem Cells Translational Medicine

Volumn 2, Issue 3, 2013, Pages 185-198

  Miltiadous, Panagiota ^a   Kouroupi, Georgia ^b   Stamatakis, Antonios ^a   Koutsoudaki, Paraskevi N ^a,b   Matsas, Rebecca ^b   Stylianopoulou, Fotini ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

Cellular therapy; Experimental models; Insulin like growth factors; Neural stem cell; Stem cell transplantation

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE TRANSPORTER; GREEN FLUORESCENT PROTEIN; KAINIC ACID; NESTIN; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN GRAFT; CELL TRANSPLANTATION; COGNITION; CONTROLLED STUDY; DENTATE GYRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPAL DEGENERATION; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LEARNING; MAZE TEST; MEMORY; MOUSE; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEUROPATHY; NONHUMAN; TEMPORAL LOBE EPILEPSY; VIRAL GENE DELIVERY SYSTEM;

EID: 84875116124     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2012-0074     Document Type: Article

References (64)

1. Helmstaedter C. Effects of chronic epilepsy on declarative memory systems. Prog Brain Res 2002;135:439-453.
2. Rossi F, Cattaneo E. Opinion: Neural stem cell therapy for neurological diseases: Dreams and reality. Nat Rev Neurosci 2002; 3:401-409.
3. Kan EM, Ling EA, Lu J. Stem cell therapy for spinal cord injury. Curr Med Chem 2010;17: 4492-4510.
4. Brundin P, Barker RA, Parmar M. Neural grafting in Parkinson's disease: Problems and possibilities. Prog Brain Res 2010;184:265-294.
5. Schwarz SC, Schwarz J. Translation of stem cell therapy for neurological diseases. Transl Res 2010;156:155-160.
6. Shetty AK, Hattiangady B. Concise review: Prospects of stem cell therapy for temporal lobe epilepsy. STEM CELLS 2007;25:2396-2407.
7. Naegele JR, Maisano X, Yang J et al. Recent advancements in stem cell and gene therapies for neurological disorders and intractable epilepsy. Neuropharmacology 2010;58:855-864.
8. Shetty AK. Progress in cell grafting therapy for temporal lobe epilepsy. Neurotherapeutics 2011;8:721-735.
9. Maisano X, Litvina E, Tagliatela S et al. Differentiation and functional incorporation of embryonic stem cell-derived GABAergic interneurons in the dentate gyrus of mice with temporal lobe epilepsy. J Neurosci 2012;32: 46-61.
10. Guan J, Bennet L, Gluckman PD et al. Insulin-like growth factor-1 and post-ischemic brain injury. Prog Neurobiol 2003;70: 443-462.
11. Kazanis I, Bozas E, Philippidis H et al. Neuroprotective effects of insulin-like growth factor-I (IGF-I) following a penetrating brain injury in rats. Brain Res 2003;991:34-45.
12. Liu XF, Fawcett JR, R. HL et al. The window of opportunity for treatment of focal cerebral ischemic damage with noninvasive intranasal insulin-like growth factor-I in rats. J Stroke Cerebrovasc Dis 2004;13:16-23.
13. Kaspar BK, Llado J, Sherkat N et al. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 2003;301:839-842.
14. Chesik D, Wilczak N, De Keyser J. The insulin-like growth factor system in multiple sclerosis. Int Rev Neurobiol 2007;79:203-226.
15. Torres-Aleman I. Targeting insulin-like growth factor-1 to treat Alzheimer's disease. Expert Opin Ther Targets 2007;11:1535-1542.
16. Ebert AD, Beres AJ, Barber AE et al. Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease. Exp Neurol 2008;209:213-223.
17. Fernandez AM, Carro EM, Lopez-Lopez C et al. Insulin-like growth factor I treatment for cerebellar ataxia: Addressing a common pathway in the pathological cascade? Brain Res Brain Res Rev 2005;50:134-141.
18. Miltiadous P, Stamatakis A, Koutsoudaki PN et al. IGF-I ameliorates hippocampal neurodegeneration and protects against cognitive deficits in an animal model of temporal lobe epilepsy. Exp Neurol 2011; 231:223-235.
19. Miltiadous P, Stamatakis A, Stylianopoulou F. Neuroprotective effects of IGF-I following kainic acid-induced hippocampal degeneration in the rat. Cell Mol Neurobiol 2010;30: 347-360.
20. Kouroupi G, Lavdas AA, Gaitanou M et al. Lentivirus-mediated expression of insulin-like growth factor-I promotes neural stem/precursor cell proliferation and enhances their potential to generate neurons. J Neurochem 2010; 115:460-474.
21. Kuruba R, Hattiangady B, Shetty AK. Hippocampal neurogenesis and neural stem cells in temporal lobe epilepsy. Epilepsy Behav 2009;14(suppl 1):65-73.
22. Parent JM, Lowenstein DH. Seizure-induced neurogenesis: Are more new neurons good for an adult brain? Prog Brain Res 2002; 135:121-131.
23. Katsimpardi L, Gaitanou M, Malnou CE et al. BM88/Cend1 expression levels are critical for proliferation and differentiation of subventricular zone-derived neural precursor cells. STEM CELLS 2008;26:1796-1807.
24. Shetty AK, Turner DA. Vulnerability of the dentate gyrus to aging and intracerebroventricular administration of kainic acid. Exp Neurol 1999;158:491-503.
25. Lothman EW, Collins RC. Kainic acid induced limbic seizures: Metabolic, behavioral, electroencephalographic and neuropathological correlates. Brain Res 1981;218:299-318.
26. Makri G, Lavdas AA, Katsimpardi L et al. Transplantation of embryonic neural stem/ precursor cells overexpressing BM88/Cend1 enhances the generation of neuronal cells in the injured mouse cortex. STEM CELLS 2010;28: 127-139.
27. Ohlsson M, Mattsson P, Svensson M. A temporal study of axonal degeneration and glial scar formation following a standardized crush injury of the optic nerve in the adult rat. Restor Neurol Neurosci 2004;22:1-10.
28. Steiner B, Zurborg S, Horster H et al. Differential 24 h responsiveness of Prox1-expressing precursor cells in adult hippocampal neurogenesis to physical activity, environmental enrichment, and kainic acid-induced seizures. Neuroscience 2008;154: 521-529.
29. Hartman NW, Carpentino JE, LaMonica K et al. CXCL12-mediated guidance of migrating embryonic stem cell-derived neural progenitors transplanted into the hippocampus. PLoS One 2010;5:e15856.
30. Löscher W, Gernert M, Heinemann U. Cell and gene therapies in epilepsy: Promising avenues or blind alleys? Trends Neurosci 2008; 31:62-73.
31. Hattiangady B, Rao MS, Shetty AK. Grafting of striatal precursor cells into hippocampus shortly after status epilepticus restrains chronic temporal lobe epilepsy. Exp Neurol 2008;212:468-481.
32. Holmes GL, Thompson JL, Huh K et al. Effect of neural transplants on seizure frequency and kindling in immature rats following kainic acid. Brain Res Dev Brain Res 1991;64: 47-56.
33. Rao MS, Hattiangady B, Rai KS et al. Strategies for promoting anti-seizure effects of hippocampal fetal cells grafted into the hippocampus of rats exhibiting chronic temporal lobe epilepsy. Neurobiol Dis 2007;27: 117-132.
34. Waldau B, Hattiangady B, Kuruba R et al. Medial ganglionic eminence-derived neural stem cell grafts ease spontaneous seizures and restore GDNF expression in a rat model of chronic temporal lobe epilepsy. STEM CELLS 2010;28:1153-1164.
35. Boison D. Engineered adenosine-releasing cells for epilepsy therapy: Human mesenchymal stem cells and human embryonic stem cells. Neurotherapeutics 2009;6:278-283.
36. Li T, Steinbeck JA, Lusardi T et al. Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain implants. Brain 2007;130:1276-1288.
37. Li T, Ren G, Kaplan DL et al. Human mesenchymal stem cell grafts engineered to release adenosine reduce chronic seizures in a mouse model of CA3-selective epileptogenesis. Epilepsy Res 2009;84:238-241.
38. Di Giovanni S, Movsesyan V, Ahmed F et al. Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury. Proc Natl Acad Sci USA 2005;102:8333-8338.
39. Kazanis I, Giannakopoulou M, Philippidis H et al. Alterations in IGF-I, BDNF and NT-3 levels following experimental brain trauma and the effect of IGF-I administration. Exp Neurol 2004;186:221-234.
40. Oberheim NA, Tian GF, Han X et al. Loss of astrocytic domain organization in the epileptic brain. J Neurosci 2008;28:3264-3276.
41. Ridet JL, Malhotra SK, Privat A et al. Reactive astrocytes: Cellular and molecular cues to biological function. Trends Neurosci 1997; 20:570-577.
42. Binder DK, Steinhauser C. Functional changes in astroglial cells in epilepsy. Glia 2006;54:358-368.
43. de Lanerolle NC, Lee TS. New facets of the neuropathology and molecular profile of human temporal lobe epilepsy. Epilepsy Behav 2005;7:190-203.
44. Heinemann U, Gabriel S, Jauch R et al. Alterations of glial cell function in temporal lobe epilepsy. Epilepsia 2000;41(suppl 6): S185-S189.
45. Seifert G, Schilling K, Steinhauser C. Astrocyte dysfunction in neurological disorders: A molecular perspective. Nat Rev Neurosci 2006;7:194-206.
46. Turner RS. Chromatolysis and recovery of efferent neurons. J Comp Neurol 1943;79: 73-78.
47. Insausti R, Amaral DG. The Human Nervous System. Amsterdam, The Netherlands: Elsevier, 2004.
48. Laurberg S. Commissural and intrinsic connections of the rat hippocampus. J Comp Neurol 1979;184:685-708.
49. Voneida TJ, Vardaris RM, Fish SE et al. The origin of the hippocampal commissure in the rat. Anat Rec 1981;201:91-103.
50. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 1985;14:375-403.
51. Florian C, Mons N, Roullet P. CREB antisense oligodeoxynucleotide administration into the dorsal hippocampal CA3 region impairs long- but not short-term spatial memory in mice. Learn Mem 2006;13:465-472.
52. Gold AE, Kesner RP. The role of the CA3 subregion of the dorsal hippocampus in spatial pattern completion in the rat. Hippocampus 2005;15:808-814.
53. Kesner RP, Lee I, Gilbert P. A behavioral assessment of hippocampal function based on a subregional analysis. Rev Neurosci 2004;15: 333-351.
54. Gluckman PD, Guan J, Williams C et al. Asphyxial brain injury: the role of the IGF system. Mol Cell Endocrinol 1998;140:95-99.
55. Park E, Bell JD, Baker AJ. Traumatic brain injury: Can the consequences be stopped? CMAJ 2008;178:1163-1170.
56. Jessberger S, Romer B, Babu H et al. Seizures induce proliferation and dispersion of doublecortin-positive hippocampal progenitor cells. Exp Neurol 2005;196:342-351.
57. Bondy CA, Cheng CM. Signaling by insulin-like growth factor 1 in brain. Eur J Pharmacol 2004;490:25-31.
58. Bondy CA, Cheng CM. Insulin-like growth factor-1 promotes neuronal glucose utilization during brain development and repair processes. Int Rev Neurobiol 2002;51:189-217.
59. Carpentino JE, Hartman NW, Grabel LB et al. Region-specific differentiation of embryonic stem cell-derived neural progenitor transplants into the adult mouse hippocampus following seizures. J Neurosci Res 2008; 86:512-524.
60. Hurtado-Chong A, Yusta-Boyo MJ, Vergano-Vera E et al. IGF-I promotes neuronal migration and positioning in the olfactory bulb and the exit of neuroblasts from the subventricular zone. Eur J Neurosci 2009;30:742-755.
61. Sequerra EB, Miyakoshi LM, Froes MM et al. Generation of glutamatergic neurons from postnatal and adult subventricular zone with pyramidal-like morphology. Cereb Cortex 2010;20:2583-2591.
62. Bluthé RM, Frenois F, Kelley KW et al. Pentoxifylline and insulin-like growth factor-I (IGF-I) abrogate kainic acid-induced cognitive impairment in mice. J Neuroimmunol 2005; 169:50-58.
63. Singleton JR, Dixit VM, Feldman EL. Type I insulin-like growth factor receptor activation regulates apoptotic proteins. J Biol Chem 1996; 271:31791-31794.
64. Pleasure SJ, Anderson S, Hevner R et al. Cell migration from the ganglionic eminences is required for the development of hippocampal GABAergic interneurons. Neuron 2000;28: 727-740.